Apple has quietly broadened the reach of two of its most innovative health-monitoring tools—sleep apnea detection and advanced heart‑health features—bringing them to a raft of new territories across Europe, Asia, Latin America, and beyond. For users in markets that have long awaited these capabilities, the expansion could mean earlier awareness of potentially serious health conditions, delivered straight from their wrists.

Sleep apnea is a common—but often undiagnosed—condition in which breathing repeatedly stops and starts during slumber, leading to fragmented rest and a range of downstream health risks, from daytime fatigue to cardiovascular strain. Experts estimate that tens of millions worldwide suffer from moderate to severe sleep apnea, yet many remain unaware of their condition until long after it has begun to take its toll.

Apple’s sleep apnea detection, introduced earlier this year in conjunction with watchOS 11, leverages the accelerometer inside the Apple Watch to sense minute wrist movements associated with interruptions in breathing patterns. Over successive nights, the watch analyzes these “breathing disturbances” and, if moderate to severe patterns emerge, alerts the wearer and logs the data in the Health app on iPhone for further review.

Rather than relying on audio—like many home sleep tests—the Apple Watch tracks subtle shifts in wrist motion during a 30‑minute window each night. These motion signatures, when aggregated over multiple nights, can flag episodes where the wearer’s respiration paused or became erratic. Once activated, the feature requires users to wear their Watch to bed for at least several consecutive nights to establish a baseline and detect any abnormal patterns.

Compatibility is limited to the latest hardware: Series 9, Series 10, and Ultra 2 models running watchOS 11 or later. After the initial monitoring period, nightly breathing disturbances appear as a dedicated chart in the Health app, empowering users to share detailed reports—including a PDF summary—with medical professionals if needed.

With this rollout, Apple has brought its sleep apnea feature to the following additional regions:

• Argentina
• Australia
• Christmas Island
• Cocos (Keeling) Islands
• Ecuador
• Heard and McDonald Islands
• Honduras
• Indonesia
• Moldova
• Norfolk Island
• Serbia
• Taiwan
• Thailand
• Ukraine
• Vietnam

These markets join more than 150 countries and regions worldwide where sleep apnea detection is already offered. Notably, Apple secured regulatory approvals in key territories—such as Taiwan’s Ministry of Health and Welfare—before activation, aligning its wearable as a bona fide medical‑grade monitoring tool rather than a simple wellness gadget.

Apple didn’t stop at sleep. Its suite of heart‑health features—ECG readings, Irregular Heart Rhythm Notifications, and AFib History—has also gained traction in new locales. These tools work as follows:

• ECG: Offers a single‑lead electrocardiogram to detect atrial fibrillation, high or low heart rates, and other anomalies.
• Irregular Rhythm Notifications: Passively monitors heart rhythm in the background, pinging users if it spots patterns typical of AFib.
• AFib History: For users already diagnosed with atrial fibrillation, this feature tracks the frequency and duration of AFib episodes and shows them in the Health app.

As of this update, ECG readings and Irregular Rhythm Notifications have launched in Argentina, Costa Rica, and Serbia, while AFib History is now live in Argentina and Serbia—expanding access to populations where atrial fibrillation remains underdiagnosed and under‑monitored. All three features are available on the same Watch models that support sleep apnea detection and span more than 150 countries globally.

For Apple Watch owners in these newly added regions, the update requires nothing more than the latest watchOS software and a willingness to wear the device overnight. Once enabled in the Health app’s “Respiratory” section, sleep apnea notifications will run automatically, joining the roster of health insights that already includes blood‑oxygen monitoring and cycle tracking.

On the heart side, users can initiate an ECG anytime via the ECG app or simply rely on background rhythm monitoring. AFib History, meanwhile, necessitates a physician’s prior diagnosis to unlock detailed tracking, turning the Watch into a personal AFib diary.

By integrating clinically‑validated features into a consumer wearable, Apple aims to lower barriers between everyday users and actionable health data—potentially catching conditions before they escalate.

Apple’s ongoing expansion of health features underscores a broader industry trend: embedding medical‑grade sensors and algorithms into mass‑market devices. With rivals like Samsung rolling out their own sleep‑disordered breathing detection, consumers stand to benefit from more informed choices about their health routines.

As these tools proliferate, questions about data privacy, algorithmic accuracy, and regulatory oversight will intensify. For now, users—whether in Brazil or Bali—can look forward to a future where their smartwatch does more than tell time: it becomes a nightly sentinel for sleep quality and a vigilant guard for cardiovascular well‑being.